Found: 10
Select item for more details and to access through your institution.
Impact of Early Access Reform on Oncology Innovation in France: Approvals, Patients, and Costs.
- Published in:
- BioDrugs, 2024, v. 38, n. 3, p. 465, doi. 10.1007/s40259-024-00658-1
- By:
- Publication type:
- Article
CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance.
- Published in:
- BioDrugs, 2024, v. 38, n. 3, p. 387, doi. 10.1007/s40259-024-00656-3
- By:
- Publication type:
- Article
Additional Data in Expanded Patient Populations and New Indications Support the Practice of Biosimilar-to-Biosimilar Switching.
- Published in:
- BioDrugs, 2024, v. 38, n. 3, p. 331, doi. 10.1007/s40259-024-00655-4
- By:
- Publication type:
- Article
Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a Highlight.
- Published in:
- BioDrugs, 2024, v. 38, n. 3, p. 369, doi. 10.1007/s40259-024-00654-5
- By:
- Publication type:
- Article
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database.
- Published in:
- BioDrugs, 2024, v. 38, n. 3, p. 425, doi. 10.1007/s40259-024-00653-6
- By:
- Publication type:
- Article
Can Endangered Biosimilar Markets be Rescued? The Need to Bridge Competing Interests for Long-Term Gain.
- Published in:
- BioDrugs, 2024, v. 38, n. 3, p. 325, doi. 10.1007/s40259-024-00652-7
- By:
- Publication type:
- Article
Research Advances in Stem Cell Therapy for Erectile Dysfunction.
- Published in:
- BioDrugs, 2024, v. 38, n. 3, p. 353, doi. 10.1007/s40259-024-00650-9
- By:
- Publication type:
- Article
Use of Biosimilars: A Systematic Review of Published Position Statements and Recommendations from Health Organisations and Societies.
- Published in:
- BioDrugs, 2024, v. 38, n. 3, p. 405, doi. 10.1007/s40259-024-00649-2
- By:
- Publication type:
- Article
Next-Generation Anti-TNFα Agents: The Example of Ozoralizumab.
- Published in:
- BioDrugs, 2024, v. 38, n. 3, p. 341, doi. 10.1007/s40259-024-00648-3
- By:
- Publication type:
- Article
Consensus-Based Overarching Principles and Recommendations on the Use of Biosimilars in the Treatment of Inflammatory Arthritis in the Gulf Region.
- Published in:
- BioDrugs, 2024, v. 38, n. 3, p. 449, doi. 10.1007/s40259-023-00642-1
- By:
- Publication type:
- Article